| 5.9 0.64 (12.17%) | 04-20 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 13.43 | 1-year : | 17.93 |
| Resists | First : | 11.49 | Second : | 15.35 |
| Pivot price | 7.53  |
|||
| Supports | First : | 5.26 | Second : | 4.37 |
| MAs | MA(5) : | 6.07 |
MA(20) : | 8.17 |
| MA(100) : | 27.9 |
MA(250) : | 46.06 |
|
| MACD | MACD : | -2.1 |
Signal : | -2.2 |
| %K %D | K(14,3) : | 3.4 |
D(3) : | 1.9 |
| RSI | RSI(14): 30.4 |
|||
| 52-week | High : | 86 | Low : | 5.26 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ EUDA ] has closed above bottom band by 24.7%. Bollinger Bands are 61.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 22 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 6.69 - 6.73 | 6.73 - 6.77 |
| Low: | 5.58 - 5.62 | 5.62 - 5.66 |
| Close: | 5.84 - 5.9 | 5.9 - 5.96 |
EUDA Health Limited develops digital health platform that offers virtual consults for non-emergency medical issues. The company was founded in 2019 and is based in Singapore. EUDA Health Limited company operates as a subsidiary of Watermark Developments Limited.
Fri, 17 Apr 2026
Bo Huang Net Worth (2026) - GuruFocus
Fri, 17 Apr 2026
Whye Shin Tay Net Worth (2026) - GuruFocus
Thu, 19 Mar 2026
EUDA Health Holdings Limited announced that the company will implement a 1-for-20 reverse stock split of its ordinary shares. - Bitget
Thu, 19 Mar 2026
EUDA Health executes 1-for-20 reverse stock split - Investing.com
Thu, 19 Mar 2026
EUDA Health Holdings Limited Announces 1-for-20 Reverse Stock Split Effective March 23, 2026 - Quiver Quantitative
Wed, 04 Mar 2026
EUDA Health scraps warrant that could issue 2M new shares - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 2 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 37.2 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 6 (K) |
| Shares Short P.Month | 4 (K) |
| EPS | 0.4 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -2 |
| Profit Margin | 5.1 % |
| Operating Margin | -37.1 % |
| Return on Assets (ttm) | -64 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 60.2 % |
| Gross Profit (p.s.) | 0.61 |
| Sales Per Share | 2.73 |
| EBITDA (p.s.) | -1.06 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -2 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | 14.75 |
| PEG Ratio | 0 |
| Price to Book value | -2.96 |
| Price to Sales | 2.16 |
| Price to Cash Flow | -5.61 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|